Alcresta Therapeutics provides financial assistance for RELiZORB to eligible patients. Click the tab to expand and learn more about each program.
RELiZORB Out-of-Pocket Assistance Program
Assistance with out-of-pocket expenses, such as co-pays, co-insurance or deductibles. Read more >
For eligible patients with commercial health insurance, the RELiZORB Out-of-Pocket Assistance Program assists with out-of-pocket expenses, which can include co-pays, co-insurance, or deductibles.
Who is Eligible for the RELiZORB Out-of-Pocket Assistance Program?
The program is open to individuals who:
- Have commercial insurance
- Are prescribed RELiZORB
If You Qualify, Enrollment in the Program is Automatic
If you are eligible, you will be enrolled in the program when RELiZORB Support Services reviews your commercial insurance benefits. Enrollment in the program is subject to confirmation of eligibility.
How Much Could I Save?
The program requires the patient to pay a minimum of $50 or the full amount of their co-pay, co-insurance, or deductibles, whichever is less, for each 30 count box of RELiZORB.
There is no out-of-pocket assistance card required — your benefit will be automatically deducted from your bill.*
*The program provides a maximum $300 benefit for each 30-count pack.
Program Terms and Conditions
- This program covers the cost of RELiZORB out-of-pocket costs. Examples of the types of out-of-pocket expenses that are covered include co-payment, co-insurance and/or deductibles
- Eligible patients must have a prescription for RELiZORB
- Eligible patients must have commercial insurance that covers RELiZORB
- Persons enrolled in any government healthcare program, such as Medicare, Managed Medicare, Medicaid, Managed Medicaid, Tricare, Triwest, and Veterans Administration are not eligible for the RELiZORB Out-of-Pocket Assistance Program
- All coverage requirements mandated by the insurance company of the eligible patient must be satisfied in order for the program to take effect
- Patients who move from commercial to federally funded insurance will no longer be eligible for the program
- Federally funded commercial insurance plans are NOT eligible
- Enrollment period is for 12 months; after that you will be re-evaluated for continued eligibility for the program
- Alcresta Therapeutics reserves the right to rescind, revoke, amend, or terminate this program at any time
- This program is not health insurance
- By using this out-of-pocket financial assistance benefit, you acknowledge and attest that you currently meet the eligibility criteria and will comply with the program terms and conditions
RELiZORB Patient Assistance Program
Financial assistance for patients with limited options. Read more >
RELiZORB is available at no cost to patients experiencing financial difficulties through the RELiZORB Patient Assistance Program (PAP). Eligible patients typically have no healthcare coverage for the requested product and do not have access to alternative sources of coverage or funding. All applications are reviewed on a case-by-case basis to support the RELiZORB Patient Assistance Program’s purpose of providing products at no cost to individuals in need.
How to Enroll in the RELiZORB Patient Assistance Program
An enrollment form is available from RELiZORB Support Services by calling 1-844-632-9271. The following checklist should be used when completing the application.
Checklist for Submitting an Application:
□ Ensure all sections of the application are completed
□ Attach current proof of income (tax return, W2, pay stub) for all in household
□ Prescriber’s signature/date is required on Page 1 of the application
□ Patient’s signature/date is required on Page 2 and Page 3 of the application
□ Complete the Patient Enrollment Form
Email or fax the completed documentation to RelizorbOrder@asembia.com or 1-844-233-3146
RELiZORB Support Services Is Here to Help
With one call, patients using RELiZORB have access to a range of helpful support services, such as financial assistance.
A dedicated program coordinator is standing by, ready to help.
Just call 1-844-632-9271.